Cargando…

Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)

We describe a case of a 4-year-old girl with Burkitt's lymphoma, who suffered from a massive gastrointestinal hemorrhage 3 days after chemotherapy. In spite of applying the common practice in correction of coagulopathy, thrombocytopenia persisted and bleeding became life-threatening. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goudarzi Pour, Kourosh, Malek, Fatemeh, Eshghi, Peyman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958449/ https://www.ncbi.nlm.nih.gov/pubmed/27478659 http://dx.doi.org/10.1155/2016/1295092

Ejemplares similares

Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran
por: Golestani, Mina, et al.
Publicado: (2016)

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
por: Vincent, Jean-Louis, et al.
Publicado: (2006)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
por: Bonadona, A, et al.
Publicado: (2002)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever
por: Manoj, Edirisooriya Maddumage, et al.
Publicado: (2014)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding
por: Chang, Zhi-gang, et al.
Publicado: (2020)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Use of NovoSeven(® )in cases with massive bleeding following surgery with extracorporeal circulation
por: Dementieva, I, et al.
Publicado: (2004)

The Seven Ages of Man: VII. "Sans Everything"
Publicado: (1888)

Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
por: Abuhasna, Said D., et al.
Publicado: (2012)

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding
por: Habib, Aly Makram
Publicado: (2016)

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma
por: Lee, Ju-Hee, et al.
Publicado: (2009)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

Paradoxical massive pulmonary thromboembolism in a postpartum woman with factor VII deficiency with bleeding tendency: A case report
por: Kang, Donghoon, et al.
Publicado: (2022)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

Use of Recombinant Activated Factor VII in Bleeding Lung Transplant Patients Undergoing Perioperative ECMO Therapy †
por: Laxar, Daniel, et al.
Publicado: (2023)

Massive bleeding
por: Federici, Augusto B.
Publicado: (2018)

Cardiac and Renal Malformations in a Patient with Sepsis and Severe Congenital Neutropenia
por: Eghbali, Aziz, et al.
Publicado: (2010)

Mutations of TFPI-binding exosites on factor VII cause bleeding phenotypes in factor VII deficiency
por: Seanoon, Karnsasin, et al.
Publicado: (2022)

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
por: Ng, Heng Joo, et al.
Publicado: (2006)

The hemostatic profile of recombinant activated factor VII. Can low concentrations stop bleeding in off-label indications?
por: Altman, Raul, et al.
Publicado: (2010)

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report
por: Godier, Anne, et al.
Publicado: (2018)

Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors
por: Golestani, Mina, et al.
Publicado: (2014)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

Timely ‘off-label’ use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature
por: Burad, Jyoti, et al.
Publicado: (2012)

High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy
por: Lee, Alex T., et al.
Publicado: (2016)

Small Bowel Lymphangiectasia Leading to Massive Gastrointestinal Bleeding: A Case Report
por: Safaei, Farahnaz, et al.
Publicado: (2023)

Biosimilars: the process is the product. The example of recombinant streptokinase
por: Thelwell, C, et al.
Publicado: (2014)

The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
por: Lin, Y, et al.
Publicado: (2012)

Activated factor VII in excessive bleeding during ECMO run
por: Kabbani, Mohamed Salim
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1olj3evoie7bojfkar38qcs3ol